$3.8 Million Federal Grant Given To Study Cannabis and Opiod Addiction
This week saw the National Institute of Health (NIH) receiving a federal grant of $3.8 million that will allow researchers to analyze the impact of medical cannabis on opioid use. The study, which will take five years, will be carried out by scientists from the Albert Einstein College of Medicine and the Montefiore Health System. This is a significant milestone for cannabis legalization and research, another step forward as it will help address the opioid crisis in the United States.
The research intends to understand the evidence so far that supports claims of patients stating that medical cannabis use has helped them reduce their dependency on opioids for chronic pain, enabling them to manage pain without side effects. The scientists will be using medical cannabis cultivated in New York, which is a shift from the low-quality cannabis being grown by federal contractors. The study will focus on patients suffering from chronic pain from HIV. Two hundred fifty HIV-positive and HIV-negative adults will be enrolled to participate in the study, all of whom use opioids and have been given the green light from physicians to use medical cannabis.
- New Study Shows THC Reduces Opiate Dependencyilmmj.comDecember 27, 2014
- The Feds and the NFL Both Forbid Marijuana. Both Are Studying It as an Alternative to Opiods.www.entrepreneur.comAugust 24, 2017
- The UN Drug Office Confirms The Gravity of the Opiod Crisiscannabis.net
- The role of cannabis and doctors in the opiate crisis - Lift Newsnews.lift.coDecember 6, 2016